SCNI
Scinai Immunotherapeutics
SCNI
SCNI
18 hedge funds and large institutions have $544K invested in Scinai Immunotherapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $789K → $544K (-$245K)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$94K | |
| 2 | +$70K | |
| 3 | +$34K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$8.3K |
| 5 |
Morgan Stanley
New York
|
+$6.64K |
Top Sellers
| 1 | -$200K | |
| 2 | -$74K | |
| 3 | -$44K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1K |